Authors: Allorge, D Harlow, J Boulet, O Hayhurst, GP Chowdry, J Roth, E Crewe, K Lo-Guidice, JM Lhermitte, M Broly, F Tucker, GT Ellis, SW

Citation: D. Allorge et al., In-vitro analysis of the contribution of CYP2D6.35 to ultrarapid metabolism, PHARMACOGEN, 11(8), 2001, pp. 739-741

Authors: Hayhurst, GP Lee, YH Lambert, G Ward, JM Gonzalez, FJ

Citation: Gp. Hayhurst et al., Hepatocyte nuclear factor 4 alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis, MOL CELL B, 21(4), 2001, pp. 1393-1403

Authors: Hayhurst, GP Harlow, J Chowdry, J Gross, E Hilton, E Lennard, MS Tucker, GT Ellis, SW

Citation: Gp. Hayhurst et al., Influence of phenylalanine-481 substitutions on the catalytic activity of cytochrome P450 2D6, BIOCHEM J, 355, 2001, pp. 373-379

Authors: Corchero, J Granvil, CP Akiyama, TE Hayhurst, GP Pimprale, S Feigenbaum, L Idle, JR Gonzalez, FJ

Citation: J. Corchero et al., The CYP2D6 humanized mouse: Effect of the human CYP2D6 transgene and HNF4 alpha on the disposition of debrisoquine in the mouse, MOLEC PHARM, 60(6), 2001, pp. 1260-1267

Authors: Ellis, SW Hayhurst, GP Lightfoot, T Smith, G Harlow, J Rowland-Yeo, K Larsson, C Mahling, J Lim, CK Wolf, CR Blackburn, MG Lennard, MS Tucker, GT

Citation: Sw. Ellis et al., Evidence that serine 304 is not a key ligand-binding residue in the activesite of cytochrome P450 2D6, BIOCHEM J, 345, 2000, pp. 565-571